Antibiotic resistance and vaccination in patients with urinary tract infection

Main Article Content

D.D. Ivanov


Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form resistance to antibiotics. The problem of treatment resistant, recurrent infections of the urinary tract and asymptoma­tic bacteriuria can be solved with vaccinotherapy. Urivac may recommend as an independent option or in combination with prophylactic treatment with uroanticeptic and/or phytomedicine.

Article Details

How to Cite
Ivanov, D. “Antibiotic Resistance and Vaccination in Patients With Urinary Tract Infection”. KIDNEYS, vol. 7, no. 1, Feb. 2018, pp. 2-5, doi:10.22141/2307-1257.7.1.2018.122213.
Cover story


Grabe M, Bartoletti R, Bjerklund Johansen TE, et al. EAU Guidelines on Urological Infections 2015. Available from: . Accessed: March, 2015.

Dombrovsky YaO, Ivanov DD, Herasymchuk VO. Ciprofloxacin in Urinary Tract Infection Treatment. Pochki. 2017;6(1):36-39. (in Russian).

Ivanov DD. Urinary tract infections: guidelines and clinical practice. Zdorov’ja Ukrai'ny. Pediatrija. 2017;3(42):27. (in Ukrainian).

Naber KG, Alidjanov JF. Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections? Urologiia, 2014;6:5-13. (in Russian).

Ivanov D, Abramov-Sommariva D, Moritz K, et al. An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs). Clinical Phytoscience. 2015;1:7. doi: 10.1186/s40816-015-0008-x.

Jepson R, Craig J, Williams G. Cranberry products and prevention of urinary tract infections. JAMA. 2013 Oct 2;310(13):1395-6. doi: 10.1001/jama.2013.277509.

Frellick M. Drinking More Water Reduces Repeat Urinary Tract Infections. Available from: Accessed: October 9, 2017.

García-Tello A, Gimbernat H, Redondo C, et al. Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram. Scand J Urol. 2017 Sep 11:1-6. doi: 10.1080/21681805.2017.1373698.

Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country. PLoS One. 2013;8(7):e69581. doi: 10.1371/journal.pone.0069581.

Melia M, Hynes NA. Urinary Tract Infection, Recurrent [Women]. Available from:[Women]#6. Accessed: April 5, 2017.

Bonkat G, Pickard R, Bartoletti R, et al. EAU Guidelines on Urological Infections, 2017. Available from:

Melia M. Pyelonephritis, Acute, Uncomplicated. Available from: Accessed: August 3, 2016.

Marschall J, Carpenter CR, Fowler S, Trautner BW; CDC Prevention Epicenters Program. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ. 2013 Jun 11;346:f3147. doi: 10.1136/bmj.f3147.

Hill TC, Baverstock R, Carlson KV, et al. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context. Can Urol Assoc J. 2013 Mar-Apr;7(3-4):122-30. doi: 10.5489/cuaj.337.

Bonfill X, Rigau D, Esteban-Fuertes M, et al. Efficacy and safety of urinary catheters with silver alloy coating in patients with spinal cord injury: a multicentric pragmatic randomized controlled trial. The ESCALE trial. Spine J. 2017 Nov;17(11):1650-1657. doi: 10.1016/j.spinee.2017.05.025.

Cooper FP, Alexander CE, Sinha S, Omar MI. Policies for replacing long-term indwelling urinary catheters in adults. Cochrane Database Syst Rev. 2016 Jul 26;7:CD011115. doi: 10.1002/14651858.CD011115.pub2.

Padawer D, Pastukh N, Nitzan O, et al. Catheter-associated candiduria: Risk factors, medical interventions, and antifungal susceptibility. Am J Infect Control. 2015 Jul 1;43(7):e19-22. doi: 10.1016/j.ajic.2015.03.013.

Lautenbach E. Editorial commentary: flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clin Infect Dis. 2013 Nov;57(9):1266-9. doi: 10.1093/cid/cit505.

Bystroň J. Use of bacterial lysates in clinical practice. Interni Med. 2012; 14 (1): 12-17. (in Czech).

Hanuš M, Matoušková M, Králová V, et al. Immunostimulation with polybacterial lysate (Urivac®) in preventing recurrent lower urinary tract infections. Ces urol. 2015;19(1):33-43. (in Czech).

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>